Dacron vs Dardik for Fem-Pop Bypass (DaDa)

R

Radboud University Medical Center

Status and phase

Completed
Phase 3

Conditions

Intermittent Claudication
Atheroslerosis
Arterial Occlusive Diseases

Treatments

Device: Human umbilical vein femoro-popliteal bypass
Device: heparin-bonded and collagen coated polyster

Study type

Interventional

Funder types

Other

Identifiers

NCT00523263
DaDa-trial

Details and patient eligibility

About

Clinical trial for the comparison of long-term patency of heparin-bonded Dacron and human umbilical vein vascular prostheses in above-knee femoro-popliteal bypass surgery.

Sex

All

Ages

31 to 89 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • age 31 to 89
  • intermittent claudication
  • ABI below 0.8

Exclusion criteria

  • non elective surgery
  • life expectancy below 2 yrs
  • contraindication for anticoagulant therapy

Trial design

0 participants in 2 patient groups

Dacron
Active Comparator group
Description:
Patients receiving polyester above-knee femoro-popliteal bypass
Treatment:
Device: heparin-bonded and collagen coated polyster
HUV
Active Comparator group
Description:
patients receiving HUV femoro-popliteal bypass
Treatment:
Device: Human umbilical vein femoro-popliteal bypass

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems